Press releases

(French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses

Press release | 16 Oct 2012 - 11h08 | By INSERM PRESS OFFICE
Cancer

TO CITE THIS POST :
Press release – Inserm press room (French)Un test automatisé pour évaluer la migration cellulaire et l’efficacité de nouvelles molécules anticancéreuses Link : https://presse.inserm.fr/en/french-un-test-automatis-pour-valuer-la-migration-cellulaire-et-l-efficacit-de-nouvelles-mol-cules-anticanc-reuses/4636/

Other contents In the same category :

Cancer Voir tout

communi

Metastatic Lung Cancer: A Targeted Therapy to Improve Treatment Efficacy

When faced with the most aggressive forms of lung cancer, how can the efficacy of chemotherapy be increased? Teams from Inserm, Université Paris Descartes and the Paris public hospitals system AP-HP have maybe hit on a solution. They have developed a targeted ...
communi

Inserm Research Director Jérôme Galon Wins European Inventor Award 2019

Inserm researcher Jérôme Galon has been honored by the European Patent Office (EPO) for his Immunoscore®, a test that predicts relapse risk in patients with certain forms of cancer. An achievement that encapsulates the missions and results of Inserm, a research institute ...
fermer
fermer
RSS Youtube